FDA Offers Guidance for Advair Knockoffs

One of the world's top-selling drugs—GlaxoSmithKline's asthma treatment Advair—became more vulnerable to generic competition after the FDA issued guidance on the regulatory hurdles generics companies need to pass.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news